Key Takeaways

• Nina Capital has closed its €50 million Fund III, increasing its total assets under management to over €100 million.
• The firm focuses on early-stage investments in health tech startups across Europe and North America, aiming to address urgent healthcare needs.
• Notable portfolio companies include Mindpeak and Sober Sidekick, showcasing promising innovations in cancer diagnostics and addiction recovery support.

Investment Focus and Impact

Nina Capital, a health tech venture capital firm based in Barcelona and founded by Marta-Gaia Zanchi and Marc Subirats, recently completed its €50 million Fund III. The fund has attracted diverse limited partners, including family offices and high-net-worth investors from the U.S. and Europe, raising Nina Capital’s total assets under management to over €100 million.

Since its establishment in 2019, Nina Capital has invested in 50 healthcare technology companies across nearly 20 countries, positively impacting over 10 million individuals. The firm’s mission is to provide support to innovative founders at the intersection of healthcare and technology, particularly in the early stages of company development.

Zanchi highlighted that the healthcare sector faces unique challenges due to differing market dynamics, reimbursement structures, and regulatory environments. To navigate these complexities, Nina Capital offers strategic capital, market-specific expertise, and access to a robust network, assisting startups in overcoming hurdles as they transition from early adopters to mainstream markets.

The fund primarily targets pre-seed and seed-stage investments, providing funding from €150,000 to over €1 million. With a focus on creating partnerships, the firm aims to strengthen healthcare technology solutions that bridge European startups with global markets.

In Fund III, Nina Capital is set to make investments ranging from €250,000 to €1.5 million, with specific interest in clinical innovation, healthcare infrastructure, and health data management. The recent investment in Sonar Mental Health, a U.S.-based platform supporting mental health in schools, exemplifies the firm’s commitment to impactful healthcare technologies.

Successful Portfolio Companies

Nina Capital’s previous investments have yielded impressive results, with an 80% graduation rate from seed to the next funding stage for startups in Fund I. Fund II portfolio companies have collectively increased their revenue by nearly five times within two years.

Mindpeak, a standout from its portfolio, utilizes AI-powered solutions for cancer diagnostics and has supported over 30,000 patient diagnoses. Recently, it raised $15.3 million in Series A funding. Another notable investment, Sober Sidekick, is a digital health application aimed at aiding individuals in addiction recovery. It uses an “empathy algorithm” to ensure user support and reports a significant reduction in relapse rates, supported by its recent seed funding.

Zanchi reiterates Nina Capital’s commitment to tracking advancements in AI, machine learning, and data science, expressing excitement for future innovations that can make a tangible difference in healthcare.

The content above is a summary. For more details, see the source article.